Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers
The Epstein–Barr Virus (EBV) is a double-stranded DNA-based human tumor virus that was first isolated in 1964 from lymphoma biopsies. Since its initial discovery, EBV has been identified as a major contributor to numerous cancers and chronic autoimmune disorders. The virus is particularly efficient...
Main Authors: | Atharva S. Torne, Erle S. Robertson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/5/991 |
Similar Items
-
Epstein-Barr Virus Positive Mucocutaneous Ulceration: A case report
by: Hiraa Javed, et al.
Published: (2021-10-01) -
Relationship between Epstein-Barr Virus (EBV) Infection and Viral Load in Immunosuppressive Patients
by: Meryem Çolak, et al.
Published: (2018-03-01) -
Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
by: Ruyue Chen, et al.
Published: (2023-09-01) -
Epstein-Barr virus-associated acute pancreatitis: a clinical report and review of literature
by: Salvatore Accomando, et al.
Published: (2022-09-01) -
Epstein–Barr Virus and Innate Immunity: Friends or Foes?
by: Sonia Jangra, et al.
Published: (2019-06-01)